Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Albumin (as Excipient) Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Albumin (as Excipient) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Human Serum Albumin
      • 1.3.3 Recombinant Albumin
    • 1.4 Market Segment by Application
      • 1.4.1 Global Albumin (as Excipient) Market Share by Application (2019-2025)
      • 1.4.2 Pharmaceutical & Biotechnology Industry
      • 1.4.3 Research Institutes
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Albumin (as Excipient) Market Size
      • 2.1.1 Global Albumin (as Excipient) Revenue 2014-2025
      • 2.1.2 Global Albumin (as Excipient) Sales 2014-2025
    • 2.2 Albumin (as Excipient) Growth Rate by Regions
      • 2.2.1 Global Albumin (as Excipient) Sales by Regions 2014-2019
      • 2.2.2 Global Albumin (as Excipient) Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Albumin (as Excipient) Sales by Manufacturers
      • 3.1.1 Albumin (as Excipient) Sales by Manufacturers 2014-2019
      • 3.1.2 Albumin (as Excipient) Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Albumin (as Excipient) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Albumin (as Excipient) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Albumin (as Excipient) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Albumin (as Excipient) Price by Manufacturers
    • 3.4 Key Manufacturers Albumin (as Excipient) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Albumin (as Excipient) Market
    • 3.6 Key Manufacturers Albumin (as Excipient) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Human Serum Albumin Sales and Revenue (2014-2019)
      • 4.1.2 Recombinant Albumin Sales and Revenue (2014-2019)
    • 4.2 Global Albumin (as Excipient) Sales Market Share by Type
    • 4.3 Global Albumin (as Excipient) Revenue Market Share by Type
    • 4.4 Albumin (as Excipient) Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Albumin (as Excipient) Sales by Application

    6 United States

    • 6.1 United States Albumin (as Excipient) Breakdown Data by Company
    • 6.2 United States Albumin (as Excipient) Breakdown Data by Type
    • 6.3 United States Albumin (as Excipient) Breakdown Data by Application

    7 European Union

    • 7.1 European Union Albumin (as Excipient) Breakdown Data by Company
    • 7.2 European Union Albumin (as Excipient) Breakdown Data by Type
    • 7.3 European Union Albumin (as Excipient) Breakdown Data by Application

    8 China

    • 8.1 China Albumin (as Excipient) Breakdown Data by Company
    • 8.2 China Albumin (as Excipient) Breakdown Data by Type
    • 8.3 China Albumin (as Excipient) Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Albumin (as Excipient) Breakdown Data by Company
    • 9.2 Rest of World Albumin (as Excipient) Breakdown Data by Type
    • 9.3 Rest of World Albumin (as Excipient) Breakdown Data by Application
    • 9.4 Rest of World Albumin (as Excipient) Breakdown Data by Countries
      • 9.4.1 Rest of World Albumin (as Excipient) Sales by Countries
      • 9.4.2 Rest of World Albumin (as Excipient) Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Albumedix A/S (Novozyme A/S)
      • 10.1.1 Albumedix A/S (Novozyme A/S) Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Albumin (as Excipient)
      • 10.1.4 Albumin (as Excipient) Product Introduction
      • 10.1.5 Albumedix A/S (Novozyme A/S) Recent Development
    • 10.2 Albumin Therapeutics
      • 10.2.1 Albumin Therapeutics Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Albumin (as Excipient)
      • 10.2.4 Albumin (as Excipient) Product Introduction
      • 10.2.5 Albumin Therapeutics Recent Development
    • 10.3 Biotest
      • 10.3.1 Biotest Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Albumin (as Excipient)
      • 10.3.4 Albumin (as Excipient) Product Introduction
      • 10.3.5 Biotest Recent Development
    • 10.4 CSL Behring
      • 10.4.1 CSL Behring Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Albumin (as Excipient)
      • 10.4.4 Albumin (as Excipient) Product Introduction
      • 10.4.5 CSL Behring Recent Development
    • 10.5 Grifols International
      • 10.5.1 Grifols International Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Albumin (as Excipient)
      • 10.5.4 Albumin (as Excipient) Product Introduction
      • 10.5.5 Grifols International Recent Development
    • 10.6 HiMedia Laboratories
      • 10.6.1 HiMedia Laboratories Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Albumin (as Excipient)
      • 10.6.4 Albumin (as Excipient) Product Introduction
      • 10.6.5 HiMedia Laboratories Recent Development
    • 10.7 InVitria
      • 10.7.1 InVitria Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Albumin (as Excipient)
      • 10.7.4 Albumin (as Excipient) Product Introduction
      • 10.7.5 InVitria Recent Development
    • 10.8 Medxbio
      • 10.8.1 Medxbio Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Albumin (as Excipient)
      • 10.8.4 Albumin (as Excipient) Product Introduction
      • 10.8.5 Medxbio Recent Development
    • 10.9 Octapharma
      • 10.9.1 Octapharma Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Albumin (as Excipient)
      • 10.9.4 Albumin (as Excipient) Product Introduction
      • 10.9.5 Octapharma Recent Development
    • 10.10 RayBiotech
      • 10.10.1 RayBiotech Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Albumin (as Excipient)
      • 10.10.4 Albumin (as Excipient) Product Introduction
      • 10.10.5 RayBiotech Recent Development
    • 10.11 SeraCare Life Sciences
    • 10.12 Merck

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Albumin (as Excipient) Sales Channels
      • 11.2.2 Albumin (as Excipient) Distributors
    • 11.3 Albumin (as Excipient) Customers

    12 Market Forecast

    • 12.1 Global Albumin (as Excipient) Sales and Revenue Forecast 2019-2025
    • 12.2 Global Albumin (as Excipient) Sales Forecast by Type
    • 12.3 Global Albumin (as Excipient) Sales Forecast by Application
    • 12.4 Albumin (as Excipient) Forecast by Regions
      • 12.4.1 Global Albumin (as Excipient) Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Albumin (as Excipient) Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Albumin is a water soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries
      Increase in usage of albumin as multifunctional excipient, shift toward usage of recombinant albumin, and grant of regulatory approvals are the key factors driving the market. However, high cost and expertise required to set up production plants and stringent regulatory criteria restrain the market. Emerging markets such as India, China, Brazil, and South Africa present significant opportunities in the albumin as an excipient market owing to growing contract research manufacturing.
      In 2019, the market size of Albumin (as Excipient) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Albumin (as Excipient).

      This report studies the global market size of Albumin (as Excipient), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Albumin (as Excipient) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Albumedix A/S (Novozyme A/S)
      Albumin Therapeutics
      Biotest
      CSL Behring
      Grifols International
      HiMedia Laboratories
      InVitria
      Medxbio
      Octapharma
      RayBiotech
      SeraCare Life Sciences
      Merck

      Market Segment by Product Type
      Human Serum Albumin
      Recombinant Albumin

      Market Segment by Application
      Pharmaceutical & Biotechnology Industry
      Research Institutes
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Albumin (as Excipient) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Albumin (as Excipient) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Albumin (as Excipient) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now